BancFirst Trust & Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,362
Closed -$353K 41
2024
Q4
$353K Hold
1,362
0.16% 38
2024
Q3
$439K Hold
1,362
0.15% 32
2024
Q2
$427K Buy
1,362
+39
+3% +$11.5K 0.2% 34
2024
Q1
$376K Hold
1,323
0.18% 33
2023
Q4
$382K Hold
1,323
0.17% 28
2023
Q3
$358K Hold
1,323
0.18% 27
2023
Q2
$293K Hold
1,323
0.17% 30
2023
Q1
$320K Hold
1,323
0.19% 30
2022
Q4
$348K Sell
1,323
-31
-2% -$8.31K 0.2% 29
2022
Q3
$309K Buy
1,354
+31
+2% +$7.51K 0.18% 31
2022
Q2
$298K Hold
1,323
0.23% 35
2022
Q1
$320K Hold
1,323
0.21% 34
2021
Q4
$298K Buy
+1,323
New +$279K 0.23% 35

Other funds holding AMGN

BancFirst Trust & Investment Management's AMGN Position: Q1 2025 in Review

BancFirst Trust & Investment Management sold out of Amgen (AMGN) in Q1 2025, closing a stake of 1,362 shares — an estimated $353K sold.

BancFirst Trust & Investment Management first reported a position in AMGN in Q4 2021 and held it in 13 quarters. The position peaked at $439K in Q3 2024. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • BancFirst Trust & Investment Management reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • BancFirst Trust & Investment Management sold 1,362 Amgen shares in Q1 2025, an estimated $353K.
  • BancFirst Trust & Investment Management first reported a position in Amgen in Q4 2021 and held it in 13 quarters.
  • BancFirst Trust & Investment Management's Amgen position peaked at $439K in Q3 2024.
  • 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on BancFirst Trust & Investment Management's 13F filing for Q1 2025, filed 15 Apr 2025.